News
Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was ...
University of Liverpool wins Health Category in 2025 RSC Emerging Technologies Competition for Next-Gen Antibiotics ...
A retrospective review shows that dermatologic patients treated with mycophenolate mofetil face a significantly lower incidence of malignancy than transplant recipients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results